Back to the main directory
EarningsReview / Equity
- DAIMLER: RDOS. 4T’20 (ANÁLISIS BANCO SABADELL) by Sabadell
- Sanoma - Buy/EUR 17 (17.50): Learning-driven growth with rebased margins - Update by Nordea
- Looking ahead by BNP Paribas Exane
- Hanwha Life Insurance (088350 KS) by HSBC
- More restructuring, hard to assess outcomes by BNP Paribas Exane
- A compelling re-opening play by BNP Paribas Exane
- Baidu Inc (BIDU US) by HSBC
- PTT Global Chemical PCL (PTTGC TB) by HSBC
- Q4 execution strong, but few upgrades to 2021/22e by BNP Paribas Exane
- 10K Nuggets by BNP Paribas Exane
- Walmex (WALMEX* MM) by HSBC
- Scandic Hotels (Hold, TP: SEK31.00) - Positive, but low margin for error by DnB Markets
- TietoEVRY (Buy, TP: EUR32.00) - Layover worth the while by DnB Markets
- Kojamo (Hold, TP: EUR18.50) - High supply, but falling demand by DnB Markets
- Back to the humdrum (and 15qs) by BNP Paribas Exane
- Itaú BBA on Vesta: Solid, In-Line 4Q20 Results by Itau
- Margin recovery will take time by BNP Paribas Exane
- Truck traffic may never return by BNP Paribas Exane
- A Stress Test Tool-Kit by BNP Paribas Exane
- Kojamo - Still decent growth, now at a lower price by Danske Bank Equity Research
- Citycon - Hold: Somewhat soft Q4 and divestments hit EPS by Nordea
- Kojamo plc - Buy/EUR 20.7 (22): Growth expected to be tilted towards H2 2021 by Nordea
- Sinch - Buy/SEK 2,000 (1,575): An Inteliquent acquisition by Nordea
- Swedish Orphan Biovitrum - Buy/SEK 235 (248): Near-term worries but long-term potential by Nordea
- Reclaiming its crown by BNP Paribas Exane